VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000116 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 26, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
5,783
Total Value
$2,817,866.03
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Commercial Officer | Common Stock | โ | Feb 24, 2026 | Tax Withholding | 873 | $485.11 | $423,501.03 | 22,469 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Feb 25, 2026 | Sale | 2,500 | $486.35 | $1,215,875.00 | 19,969 | Direct | โ | View Details | |
EVP, Chief Commercial Officer | Common Stock | โ | Feb 25, 2026 | Sale | 2,410 | $489.00 | $1,178,490.00 | 17,559 | Direct | โ | View Details |